![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » BEXIMCO PHARMA INTRODUCES NEW-GENERATION INHALER AGAINST PERSISTENT ASTHMA
BEXIMCO PHARMA INTRODUCES NEW-GENERATION INHALER AGAINST PERSISTENT ASTHMA
June 5, 2006
The largest Metered Dose Inhaler manufacturer of Bangladesh, Beximco Pharmaceuticals Limited (BPL), launched a novel, new-generation corticosteroid inhaler Cesonide Sunday for treatment of adults suffering from persistent asthma. The Financial Express (http://www.financialexpress-bd.com/index3.asp?cnd=6/5/2006§ion_id=24&newsid=26770&spcl=no)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct